Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intestinal C. Difficile”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT00382304
What this trial is testing

The Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Pseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea
Genzyme, a Sanofi Company 24
Not applicableActive Not RecruitingNCT05800704
What this trial is testing

Support of Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin®

Who this might be right for
C. Difficile Enteritis
University of Zurich 49
Early research (Phase 1)Study completedNCT01551004
What this trial is testing

Phase I Trial of a Single Dose of CRS3123

Who this might be right for
Clostridium Difficile Colitis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableEnded earlyNCT02730325
What this trial is testing

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

Who this might be right for
Clostridium Difficile
Northwestern University 10
Testing effectiveness (Phase 2)Looking for participantsNCT04305769
What this trial is testing

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Who this might be right for
Clostridioides Difficile InfectionClostridium Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia 260
Testing effectiveness (Phase 2)Study completedNCT03621657
What this trial is testing

The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation

Who this might be right for
Clostridium Difficile InfectionC.Difficile DiarrheaCDI
University of Wisconsin, Madison 1
Large-scale testing (Phase 3)Ended earlyNCT03005379
What this trial is testing

Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)

Who this might be right for
Clostridium Difficile Infection
VA Office of Research and Development 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Testing effectiveness (Phase 2)Study completedNCT01230957
What this trial is testing

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Sanofi Pasteur, a Sanofi Company 650
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Early research (Phase 1)Not Yet RecruitingNCT05852587
What this trial is testing

Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Who this might be right for
Inflammatory Bowel DiseasesClostridioides Difficile Infection
Brigham and Women's Hospital 99
Early research (Phase 1)Enrolling By InvitationNCT02636517
What this trial is testing

Fecal Microbiome Transplant

Who this might be right for
Clostridium DifficileInflammatory Bowel DiseaseCrohn's Disease+1 more
Judith Kelsen 250
Large-scale testing (Phase 3)UnknownNCT02466698
What this trial is testing

Intestinal Lavage for the Treatment of Severe C. Difficile Infections

Who this might be right for
Clostridium Difficile
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Post-approval studies (Phase 4)Ended earlyNCT04626947
What this trial is testing

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more
David Binion, MD 19
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Post-approval studies (Phase 4)Ended earlyNCT03756454
What this trial is testing

Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.

Who this might be right for
Clostridia Difficile ColitisClostridium; Sepsis
Ohio State University 5
Post-approval studies (Phase 4)Active Not RecruitingNCT03663504
What this trial is testing

Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery

Who this might be right for
Elective Colon Surgery
Ottawa Hospital Research Institute 630
Post-approval studies (Phase 4)Not Yet RecruitingNCT06794944
What this trial is testing

Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Disease (IBD)Clostridioides Difficile Infection
Brigham and Women's Hospital 60
Next Page